Treatment to slow early Alzheimer’s gets TGA approval As donanemab becomes available to Australian patients, experts warn the health system must be ready for the significant shift it could bring.
Semaglutide links to eye disorders in spotlight The TGA has received 44 reports linked to the drug, but one GP says a spike in concern may not be ‘mentioning high-quality evidence’.
TGA warns of ‘possible but rare’ RSV vaccines risk Product Information for Arexvy and Abrysvo has been updated to reflect a low risk of Guillain-Barre Syndrome following vaccination.
GPs recognised for mental health leadership On World Family Doctor Day, the RACGP is celebrating GPs as frontline healthcare champions, and is urging doctors to prioritise their own wellbeing.
Established trust key to pandemic preparedness: Study It found trust and social cohesion are key to rebuilding, while GPs say their established relationships are crucial to creating change.
Further ADHD medication shortages GPs and patients have been warned to plan ahead, with Ritalin tablets already in shortage and further impacts on the way.
‘Unprecedented’ update to antibiotic guidelines The first tranche of a major update from Therapeutic Guidelines has been released, with a focus on infections treated in primary care.
‘My GP was a psychological anchor’: A patient’s long COVID story Struck down by debilitating long COVID, one patient shares her journey to recovery in a new podcast to support GPs with diagnosis and management.
TGA strengthens warnings on antibiotic side effects GPs have been asked to use fluoroquinolones ‘judiciously’, as the Administration rolls out more prominent warnings.
ADHD med shortages ‘a merry-go-round you just can’t predict’ The new school year has coincided with another series of shortages, forcing patients and prescribers to rethink their options.